These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG. Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739 [Abstract] [Full Text] [Related]
4. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M, Järvinen P, Ahonen J, Forsberg S, Leirisalo-Repo M, FIN-RACo Trial Group. Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055 [Abstract] [Full Text] [Related]
9. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR. Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851 [Abstract] [Full Text] [Related]
10. Infliximab therapy in established rheumatoid arthritis: an observational study. Voulgari PV, Alamanos Y, Nikas SN, Bougias DV, Temekonidis TI, Drosos AA. Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254 [Abstract] [Full Text] [Related]
11. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M. Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599 [Abstract] [Full Text] [Related]
12. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate. O'Dell JR, Haire C, Erikson N, Drymalski W, Palmer W, Maloley P, Klassen LW, Wees S, Moore GF. J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058 [Abstract] [Full Text] [Related]
15. Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs. Schipper LG, Fransen J, Barrera P, Van Riel PL. Rheumatology (Oxford); 2009 Jul; 48(7):828-33. PubMed ID: 19458163 [Abstract] [Full Text] [Related]